Immunotherapeutic Approaches in Pancreatic Adenocarcinoma: Current Status and Future Perspectives

E-ISSN： 1874-4702|9|3|231-241

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.9, Iss.3, 2016-09, pp. : 231-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 169-181

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches and Future Perspectives for In Vivo Clonal Tracking of Hematopoietic Cells

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 184-193

Bentham Science Publishers

Access to resources Recommend Favorite

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash Henderson David C

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite